Research Article
Which Groups of Children Are at More Risk of Fatality during COVID-19 Pandemic? A Case-Control Study in Yazd, Iran
Table 2
Underlying diseases in survived and deceased groups of children with COVID-19.
| Variables | Deceased (n = 24) | Survived (n = 167) | value | OR (95% CI) (ref: survived group) |
| Underlying diseases | Malignancy | 5 (33.33%) | 10 (14.08%) | 0.75 | 2.229 (0.912–5.447) | Neurologic | 3 (20%) | 21 (29.57%) | Nephrologic | 2 (13.33%) | 4 (5.63%) | Hematologic | 1 (6.66%) | 11 (15.49%) | Respiratory | 1 (6.66%) | 4 (5.63%) | Cardiovascular | 1 (6.66%) | 6 (8.45%) | Gastrointestinal | 1 (6.66%) | 3 (4.22%) | Genetic | 1 (6.66%) | 4 (5.63%) | Metabolic | 0 | 5 (7.04%) | Immunologic | 0 | 1 (1.40%) | Rheumatologic | 0 | 2 (2.81%) | Total | 15 (100%) | 71 (100%) |
|
|
The odds of death in children with underlying diseases was approximately 2.23 times higher than that in children without underlying diseases.
|